Teleflex Reports 250,000 Patients Treated for Enlarged Prostate with Invasive UroLift System
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) announced that, globally, 250,000 patients have been treated with the UroLift® System, a proven, minimally invasive approach to treating benign prostatic hyperplasia (BPH).
Read More